LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | I22 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.31623 | 54.74 | 27.76 | 2 | 5606 | 0.0004 | -0.2907 | MN20160318_Q01 | K08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.95 | 84.90 | 2 | 4952 | 0.0004 | -0.4722 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | 0 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | L18 | |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.31623 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | D11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | I22 |
| MCF 10A-H2B-mCherry | Alpelisib | 3.1623 | 14.58 | 84.90 | 2 | 663 | 0.0030 | -0.7174 | MN20160318_Q02 | H12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 75.93 | 84.90 | 2 | 8970 | 0.0002 | -0.4274 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | 0 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | I18 | |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 52.06 | 84.90 | 2 | 5990 | 0.0003 | -0.4569 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | 0 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | F16 | |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | 0 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | C09 | |
| MCF 10A-H2B-mCherry | Etoposide | 1.7783 | 48.65 | 84.90 | 2 | 5328 | 0.0004 | -0.4662 | MN20160318_Q02 | F20 |
| MCF 10A-H2B-mCherry | 0 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | F16 | |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 24.81 | 84.90 | 2 | 1769 | 0.0011 | -0.5749 | MN20160318_Q02 | F18 |
| MCF 10A-H2B-mCherry | Vorinostat | 10 | 78.60 | 27.76 | 2 | 7045 | 0.0003 | -0.2806 | MN20160318_Q01 | E19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.70 | 84.90 | 2 | 8484 | 0.0002 | -0.4312 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 30.90 | 27.76 | 2 | 2032 | 0.0010 | -0.3460 | MN20160318_Q01 | C15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.99 | 84.90 | 2 | 8212 | 0.0002 | -0.4335 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Vorinostat | 10 | 20.68 | 27.76 | 2 | 1119 | 0.0018 | -0.3893 | MN20160318_Q01 | C11 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | C15 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | J12 |